rs75002628
|
|
Hyperthyroxinemia, Familial Dysalbuminemic
|
C |
0.820 |
GeneticVariation
|
CLINVAR |
|
|
|
rs77892378
|
|
Hyperthyroxinemia, Familial Dysalbuminemic
|
C |
0.800 |
GeneticVariation
|
CLINVAR |
|
|
|
rs79228041
|
|
ALBUMIN B PHENOTYPE
|
A |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs77449454
|
|
Analbuminemia
|
GA |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs77408163
|
|
ANALBUMINEMIA BAGHDAD
|
A |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs77335374
|
|
Analbuminemia
|
G |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs75353611
|
|
ALBUMIN BLENHEIM PHENOTYPE
|
T |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs74821926
|
|
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1
|
A |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs75002628
|
|
Hyperthyroxinemia, Familial Dysalbuminemic
|
|
0.820 |
GeneticVariation
|
UNIPROT |
Identification of a human serum albumin species associated with familial dysalbuminemic hyperthyroxinemia.
|
7852505 |
1995 |
rs77892378
|
|
Hyperthyroxinemia, Familial Dysalbuminemic
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Identification of a human serum albumin species associated with familial dysalbuminemic hyperthyroxinemia.
|
7852505 |
1995 |
rs77238412
|
|
Analbuminemia
|
T |
0.700 |
CausalMutation
|
CLINVAR |
Analbuminemia: three cases resulting from different point mutations in the albumin gene.
|
7937781 |
1994 |
rs75002628
|
|
Hyperthyroxinemia, Familial Dysalbuminemic
|
|
0.820 |
GeneticVariation
|
UNIPROT |
An identical missense mutation in the albumin gene results in familial dysalbuminemic hyperthyroxinemia in 8 unrelated families.
|
8048949 |
1994 |
rs77892378
|
|
Hyperthyroxinemia, Familial Dysalbuminemic
|
|
0.800 |
GeneticVariation
|
UNIPROT |
An identical missense mutation in the albumin gene results in familial dysalbuminemic hyperthyroxinemia in 8 unrelated families.
|
8048949 |
1994 |
rs75002628
|
|
Hyperthyroxinemia, Familial Dysalbuminemic
|
|
0.820 |
GeneticVariation
|
UNIPROT |
A novel missense mutation in codon 218 of the albumin gene in a distinct phenotype of familial dysalbuminemic hyperthyroxinemia in a Japanese kindred.
|
9329347 |
1997 |
rs77892378
|
|
Hyperthyroxinemia, Familial Dysalbuminemic
|
|
0.800 |
GeneticVariation
|
UNIPROT |
A novel missense mutation in codon 218 of the albumin gene in a distinct phenotype of familial dysalbuminemic hyperthyroxinemia in a Japanese kindred.
|
9329347 |
1997 |
rs75002628
|
|
Hyperthyroxinemia, Familial Dysalbuminemic
|
|
0.820 |
GeneticVariation
|
UNIPROT |
Familial dysalbuminemic hypertriiodothyroninemia: a new, dominantly inherited albumin defect.
|
9589637 |
1998 |
rs77892378
|
|
Hyperthyroxinemia, Familial Dysalbuminemic
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Familial dysalbuminemic hypertriiodothyroninemia: a new, dominantly inherited albumin defect.
|
9589637 |
1998 |
rs1171303257
|
|
Malignant Neoplasms
|
|
0.010 |
GeneticVariation
|
BEFREE |
The genotype spectrum discriminated on this strip includes the high-risk, or cancer-associated, HPV genotypes 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 55, 56, 58, 59, 68 (ME180), MM4 (W13B), MM7 (P291), and MM9 (P238A) and the low-risk, or non-cancer-associated, genotypes 6, 11, 40, 42, 53, 54, 57, 66, and MM8 (P155).
|
9738060 |
1998 |
rs1171303257
|
|
Primary malignant neoplasm
|
|
0.010 |
GeneticVariation
|
BEFREE |
The genotype spectrum discriminated on this strip includes the high-risk, or cancer-associated, HPV genotypes 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 55, 56, 58, 59, 68 (ME180), MM4 (W13B), MM7 (P291), and MM9 (P238A) and the low-risk, or non-cancer-associated, genotypes 6, 11, 40, 42, 53, 54, 57, 66, and MM8 (P155).
|
9738060 |
1998 |
rs11538209
|
|
Diabetic Nephropathy
|
|
0.010 |
GeneticVariation
|
BEFREE |
Our results suggest that TGF-beta1 T29C polymorphism is not associated with the progression of diabetic nephropathy.
|
11576951 |
2001 |
rs370819889
|
|
Chronic kidney disease stage 5
|
|
0.010 |
GeneticVariation
|
BEFREE |
To evaluate the respective roles of residual glomerular filtration (by measuring a specific protein marker, cystatin C), genetic polymorphisms and nutritional status in tHcy blood levels in end-stage renal disease patients (ESRD) under hemodialysis and supplemented with folate, we measured tHcy, folate, vitamin B12 (B12), creatinine, cystatin C, albumin and C-reactive protein and determined the polymorphism of methylenetetrahydrofolate reductase (MTHFR) (C677T and A1289C) and of methionine synthase (MS) (A2756G) in 114 ESRD patients before hemodialysis and 76 control subjects.
|
11592445 |
2001 |
rs370819889
|
|
Kidney Failure, Chronic
|
|
0.010 |
GeneticVariation
|
BEFREE |
To evaluate the respective roles of residual glomerular filtration (by measuring a specific protein marker, cystatin C), genetic polymorphisms and nutritional status in tHcy blood levels in end-stage renal disease patients (ESRD) under hemodialysis and supplemented with folate, we measured tHcy, folate, vitamin B12 (B12), creatinine, cystatin C, albumin and C-reactive protein and determined the polymorphism of methylenetetrahydrofolate reductase (MTHFR) (C677T and A1289C) and of methionine synthase (MS) (A2756G) in 114 ESRD patients before hemodialysis and 76 control subjects.
|
11592445 |
2001 |
rs1162592300
|
|
Chronic kidney disease stage 5
|
|
0.010 |
GeneticVariation
|
BEFREE |
The -174G/C polymorphism of the IL-6 gene and the chemokine receptor CX3CR1 polymorphisms 249V/I and 280T/M were examined for their association with cardiovascular abnormalities in a cohort of 161 patients with end-stage renal disease (ESRD) treated by hemodialysis.
|
12846758 |
2003 |
rs1162592300
|
|
Kidney Failure, Chronic
|
|
0.010 |
GeneticVariation
|
BEFREE |
The -174G/C polymorphism of the IL-6 gene and the chemokine receptor CX3CR1 polymorphisms 249V/I and 280T/M were examined for their association with cardiovascular abnormalities in a cohort of 161 patients with end-stage renal disease (ESRD) treated by hemodialysis.
|
12846758 |
2003 |
rs1162592300
|
|
Cardiovascular Abnormalities
|
|
0.010 |
GeneticVariation
|
BEFREE |
The -174G/C polymorphism of the IL-6 gene and the chemokine receptor CX3CR1 polymorphisms 249V/I and 280T/M were examined for their association with cardiovascular abnormalities in a cohort of 161 patients with end-stage renal disease (ESRD) treated by hemodialysis.
|
12846758 |
2003 |